REGENERON PHARMACEUTICALS, INC. financials

REGN CIK 0000872589

Source: EDGAR filings · raw companyfacts JSON · Built 2026-04-25T10:15:37Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 4.08B 3.66B 3.88B 4.42B 6.53B 2.00B
EBITDA 4.12B 4.47B 4.47B 5.08B 9.23B 3.81B
Working Capital 13.65B 14.72B 16.06B 12.74B 10.08B 7.08B
Net Debt -145.40M 450.60M 60.60M -336.30M -185.90M 502.00M
Operating Margin 24.95% 28.10% 30.85% 38.93% 55.67% 42.09%
Net Margin 31.41% 31.07% 30.14% 35.64% 50.25% 41.35%
Return on Equity (ROE) 14.41% 15.03% 15.22% 19.14% 43.03% 31.86%
Return on Assets (ROA) 11.11% 11.69% 11.95% 14.85% 31.75% 20.47%
Current Ratio 4.1255 4.7311 5.69 5.0565 3.5639 3.6254
Debt-to-Equity 0.0951 0.1001 0.1074 0.1222 0.1438 0.2445
Effective Tax Rate 13.88% 7.68% 5.85% 10.71% 13.41% 7.80%
Cash Conversion Ratio 1.1052 1.0018 1.162 1.1559 0.8769 0.7452
Accruals Ratio -0.0117 -0.0002 -0.0194 -0.0232 0.0391 0.0522
SBC % of Revenue 6.93% 6.92% 6.75% 5.96% 3.74% 5.08%
CapEx Coverage 5.542 5.848 6.393 8.4984 12.8308 4.2598
Free Cash Flow Per Share $37.57 $31.84 $34.08 $38.98 $58.19 $17.41

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 18.6082 18.5793 25.26 18.8773 8.7748 15.8293
P/FCF 20.5428 22.3733 25.7681 18.5069 10.8519 27.7544
FCF Yield 4.87% 4.47% 3.88% 5.40% 9.21% 3.60%
EV / EBITDA 20.3027 18.4281 22.3635 16.0528 7.6541 14.7168
P/S 5.8444 5.7731 7.613 6.7272 4.4088 6.5441
P/B 2.6818 2.7932 3.8448 3.6132 3.7752 5.0435

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 14.34B 14.20B 13.12B 12.17B 16.07B 8.50B
Research and Development Expense 5.85B 5.13B 4.44B 3.59B 2.86B 2.65B
Selling, General and Administrative Expense 2.70B 2.95B 2.63B 2.12B 1.82B 1.35B
Operating Income (Loss) 3.58B 3.99B 4.05B 4.74B 8.95B 3.58B
Income Tax Expense (Benefit) 725.80M 367.30M 245.70M 520.40M 1.25B 297.20M
Net Income (Loss) Attributable to Parent 4.50B 4.41B 3.95B 4.34B 8.08B 3.51B
Earnings Per Share, Basic $43.07 $40.90 $37.05 $40.51 $76.40 $32.65
Weighted Average Number of Shares Outstanding, Basic 104.60M 107.90M 106.70M 107.10M 105.70M 107.60M
Earnings Per Share, Diluted $41.48 $38.34 $34.77 $38.22 $71.97 $30.52
Weighted Average Number of Shares Outstanding, Diluted 108.60M 115.10M 113.70M 113.50M 112.20M 115.10M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 3.12B 2.49B 2.73B 3.11B 2.89B 2.19B
Assets, Current 18.02B 18.66B 19.48B 15.88B 14.01B 9.78B
Assets 40.56B 37.76B 33.08B 29.21B 25.43B 17.16B
Liabilities, Current 4.37B 3.94B 3.42B 3.14B 3.93B 2.70B
Long-term Debt, Excluding Current Maturities 1.99B 1.98B 1.98B 1.98B 1.98B 1.98B
Liabilities 9.30B 8.41B 7.11B 6.55B 6.67B 6.14B
Stockholders' Equity Attributable to Parent 31.26B 29.35B 25.97B 22.66B 18.77B 11.03B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 4.98B 4.42B 4.59B 5.01B 7.08B 2.62B
Net Cash Provided by (Used in) Investing Activities -629.10M -2.47B -3.19B -3.78B -5.38B -70.60M
Payments for Repurchase of Common Stock 3.44B 2.60B 2.23B 2.08B 1.65B 5.85B
Payments of Dividends 370.30M 0 0
Net Cash Provided by (Used in) Financing Activities -3.72B -2.20B -1.79B -1.01B -1.01B -1.97B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Income Statement

23 concepts 3 units
Unit US$ · 18 concepts
Label Value Period
Other Operating Income (Expense), Net 10.00M 2025-01-01 → 2025-12-31
Interest Income, Debt Securities, Operating 716.80M 2025-01-01 → 2025-12-31
Revenue from Contract with Customer, Excluding Assessed Tax 14.34B 2025-01-01 → 2025-12-31
Equity Securities, FV-NI, Realized Gain (Loss) 966.20M 2025-01-01 → 2025-12-31
Inventory Write-down 172.90M 2025-01-01 → 2025-12-31
Costs and Expenses 10.77B 2025-01-01 → 2025-12-31
Research and Development Expense 5.85B 2025-01-01 → 2025-12-31
Amortization of Intangible Assets 178.80M 2025-01-01 → 2025-12-31
Finance Lease, Right-of-Use Asset, Amortization 14.50M 2025-01-01 → 2025-12-31
Selling, General and Administrative Expense 2.70B 2025-01-01 → 2025-12-31
Operating Income (Loss) 3.58B 2025-01-01 → 2025-12-31
Other Nonoperating Income (Expense) 1.70B 2025-01-01 → 2025-12-31
Nonoperating Income (Expense) 1.65B 2025-01-01 → 2025-12-31
Finance Lease, Interest Expense 39.10M 2025-01-01 → 2025-12-31
InterestExpenseNonoperating 43.80M 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 5.23B 2025-01-01 → 2025-12-31
Income Tax Expense (Benefit) 725.80M 2025-01-01 → 2025-12-31
Net Income (Loss) Attributable to Parent 4.50B 2025-01-01 → 2025-12-31
Unit shares · 2 concepts
Label Value Period
Weighted Average Number of Shares Outstanding, Basic 104.60M 2025-01-01 → 2025-12-31
Weighted Average Number of Shares Outstanding, Diluted 108.60M 2025-01-01 → 2025-12-31
Unit US$ / share · 3 concepts
Label Value Period
Earnings Per Share, Basic $43.07 2025-01-01 → 2025-12-31
Earnings Per Share, Diluted $41.48 2025-01-01 → 2025-12-31
Common Stock, Dividends, Per Share, Declared $0.88 2025-10-01 → 2025-12-31

Balance Sheet

45 concepts 3 units
Unit US$ · 40 concepts
Label Value Period
Cash and Cash Equivalents, at Carrying Value 3.12B as of 2025-12-31
Restricted Cash, Current 5.60M as of 2025-12-31
Marketable Securities, Current 5.49B as of 2025-12-31
Accounts Receivable, after Allowance for Credit Loss, Current 5.74B as of 2025-12-31
Debt Securities, Available-for-sale 15.71B as of 2025-12-31
Inventory, Net 3.20B as of 2025-12-31
Assets, Current 18.02B as of 2025-12-31
Operating Lease, Right-of-Use Asset 245.80M as of 2025-12-31
Finance Lease, Right-of-Use Asset, after Accumulated Amortization 576.70M as of 2025-12-31
EquitySecuritiesFVNINoncurrent 34.30M as of 2025-12-31
Marketable Securities, Noncurrent 10.26B as of 2025-12-31
Finite-Lived Intangible Assets, Gross 1.70B as of 2025-12-31
Finite-Lived Intangible Assets, Accumulated Amortization 440.70M as of 2025-12-31
Intangible Assets, Net (Excluding Goodwill) 1.26B as of 2025-12-31
Other Assets, Noncurrent 1.82B as of 2025-12-31
Deferred Income Tax Assets, Net 4.08B as of 2025-12-31
Restricted Cash, Noncurrent 0 as of 2025-12-31
Operating Lease, Liability 266.80M as of 2025-12-31
Assets 40.56B as of 2025-12-31
Accounts Payable, Current 939.00M as of 2025-12-31
Employee-related Liabilities, Current 773.00M as of 2025-12-31
Taxes Payable, Current 351.30M as of 2025-12-31
Accounts Payable and Accrued Liabilities, Current 2.88B as of 2025-12-31
Contract with Customer, Liability, Current 553.00M as of 2025-12-31
Finance Lease, Liability 720.00M as of 2025-12-31
Business Combination, Contingent Consideration, Liability 10.30M as of 2025-12-31
Liabilities, Current 4.37B as of 2025-12-31
Long-term Debt, Excluding Current Maturities 1.99B as of 2025-12-31
Finance Lease, Liability, Noncurrent 720.00M as of 2025-12-31
Contract with Customer, Liability, Noncurrent 208.70M as of 2025-12-31
Other Liabilities, Noncurrent 2.02B as of 2025-12-31
Operating Lease, Liability, Noncurrent 229.00M as of 2025-12-31
Liabilities 9.30B as of 2025-12-31
Preferred Stock, Value, Issued 0 as of 2025-12-31
Additional Paid in Capital 13.99B as of 2025-12-31
Treasury Stock, Common, Value 18.61B as of 2025-12-31
Accumulated Other Comprehensive Income (Loss), Net of Tax 77.50M as of 2025-12-31
Retained Earnings (Accumulated Deficit) 35.80B as of 2025-12-31
Stockholders' Equity Attributable to Parent 31.26B as of 2025-12-31
Liabilities and Equity 40.56B as of 2025-12-31
Unit shares · 4 concepts
Label Value Period
Preferred Stock, Shares Authorized 30.00M as of 2025-12-31
Preferred Stock, Shares Issued 0 as of 2025-12-31
Preferred Stock, Shares Outstanding 0 as of 2025-12-31
Treasury Stock, Common, Shares 33.70M as of 2025-12-31
Unit US$ / share · 1 concept
Label Value Period
Preferred Stock, Par or Stated Value Per Share $0.01 as of 2025-12-31

Cash Flow Statement

33 concepts 1 unit
Unit US$ · 33 concepts
Label Value Period
Depreciation, Depletion and Amortization 543.70M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Noncash Expense 993.70M 2025-01-01 → 2025-12-31
Operating Lease, Payments 39.60M 2025-01-01 → 2025-12-31
Interest Paid, Excluding Capitalized Interest, Operating Activities 41.60M 2025-01-01 → 2025-12-31
Deferred Income Tax Expense (Benefit) -785.40M 2025-01-01 → 2025-12-31
IncomeTaxPaidFederalAfterRefundReceived 576.50M 2025-01-01 → 2025-12-31
IncomeTaxPaidStateAndLocalAfterRefundReceived 5.30M 2025-01-01 → 2025-12-31
Income Taxes Paid, Net 1.25B 2025-01-01 → 2025-12-31
Other Noncash Income (Expense) -135.50M 2025-01-01 → 2025-12-31
Increase (Decrease) in Accounts Receivable -498.10M 2025-01-01 → 2025-12-31
Capital Expenditures Incurred but Not yet Paid 178.80M 2025-01-01 → 2025-12-31
Increase (Decrease) in Inventories 275.30M 2025-01-01 → 2025-12-31
Increase (Decrease) in Deferred Income Taxes 785.40M 2025-01-01 → 2025-12-31
Increase (Decrease) in Prepaid Expense and Other Assets 375.30M 2025-01-01 → 2025-12-31
Increase (Decrease) in Contract with Customer, Liability -51.70M 2025-01-01 → 2025-12-31
Increase (Decrease) in Accounts Payable and Accrued Liabilities 736.80M 2025-01-01 → 2025-12-31
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities 474.00M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Operating Activities 4.98B 2025-01-01 → 2025-12-31
Payments to Acquire Productive Assets 898.40M 2025-01-01 → 2025-12-31
Proceeds from Sale of Property, Plant, and Equipment 0 2025-01-01 → 2025-12-31
Payments to Acquire Marketable Securities 10.96B 2025-01-01 → 2025-12-31
Proceeds from Sale and Maturity of Marketable Securities 11.55B 2025-01-01 → 2025-12-31
Payments to Acquire Businesses, Net of Cash Acquired 3.30M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Investing Activities -629.10M 2025-01-01 → 2025-12-31
Proceeds from Issuance of Common Stock 635.90M 2025-01-01 → 2025-12-31
Payments for Repurchase of Common Stock 3.44B 2025-01-01 → 2025-12-31
Payments of Dividends 370.30M 2025-01-01 → 2025-12-31
Payment, Tax Withholding, Share-based Payment Arrangement 532.10M 2025-01-01 → 2025-12-31
Proceeds from (Payments for) Other Financing Activities -10.30M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Financing Activities -3.72B 2025-01-01 → 2025-12-31
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 300.00K 2025-01-01 → 2025-12-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 634.70M 2025-01-01 → 2025-12-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.12B as of 2025-12-31

Notes

100 concepts 3 units
Unit US$ · 87 concepts
Label Value Period
Finance Lease, Right-of-Use Asset, Accumulated Amortization 162.90M as of 2025-12-31
Current Federal Tax Expense (Benefit) 1.01B 2025-01-01 → 2025-12-31
Current State and Local Tax Expense (Benefit) 19.80M 2025-01-01 → 2025-12-31
Current Foreign Tax Expense (Benefit) 479.10M 2025-01-01 → 2025-12-31
Current Income Tax Expense (Benefit) 1.51B 2025-01-01 → 2025-12-31
Cash and Cash Equivalents, Fair Value Disclosure 2.12B as of 2025-12-31
Deferred Federal Income Tax Expense (Benefit) -845.20M 2025-01-01 → 2025-12-31
Deferred State and Local Income Tax Expense (Benefit) -15.50M 2025-01-01 → 2025-12-31
Deferred Foreign Income Tax Expense (Benefit) 75.30M 2025-01-01 → 2025-12-31
Operating Lease, Liability, Current 37.80M as of 2025-12-31
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability 44.50M 2025-01-01 → 2025-12-31
Prepaid Expense and Other Assets, Current 474.80M as of 2025-12-31
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization 7.73B as of 2025-12-31
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization 2.61B as of 2025-12-31
Other Accrued Liabilities, Current 519.30M as of 2025-12-31
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization 5.12B as of 2025-12-31
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount 870.80M as of 2025-12-31
SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account 3.29B 2025-01-01 → 2025-12-31
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 3.18B 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 1.10B 2025-01-01 → 2025-12-31
EffectiveIncomeTaxRateReconciliationFdiiAmount 20.60M 2025-01-01 → 2025-12-31
EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount 8.30M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 133.30M 2025-01-01 → 2025-12-31
Inventory, Finished Goods, Net of Reserves 190.20M as of 2025-12-31
Inventory, Work in Process, Net of Reserves 1.64B as of 2025-12-31
Inventory, Raw Materials, Net of Reserves 641.50M as of 2025-12-31
Other Inventory, Net of Reserves 727.50M as of 2025-12-31
Equity Securities, FV-NI, Unrealized Gain (Loss) -10.60M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 14.10M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 27.00M 2025-01-01 → 2025-12-31
Equity Securities, FV-NI, Gain (Loss) 955.60M 2025-01-01 → 2025-12-31
Equity Securities without Readily Determinable Fair Value, Amount 334.00M as of 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 124.20M 2025-01-01 → 2025-12-31
Dividends, Common Stock 376.60M 2025-01-01 → 2025-12-31
Accrued Liabilities and Other Liabilities 2.88B as of 2025-12-31
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 44.50M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 4.30M 2025-01-01 → 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year One 124.00M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Two 124.00M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Three 124.00M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Four 124.00M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Five 124.00M as of 2025-12-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One 5.49B as of 2025-12-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five 10.22B as of 2025-12-31
Stock Repurchase Program, Remaining Authorized Repurchase Amount 1.49B as of 2025-12-31
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 576.20M 2025-01-01 → 2025-12-31
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax 98.50M as of 2025-12-31
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 2.50M as of 2025-12-31
Stock Repurchased During Period, Value 3.46B 2025-01-01 → 2025-12-31
Deferred Tax Assets, Tax Credit Carryforwards 79.60M as of 2025-12-31
Operating Lease, Cost 35.80M 2025-01-01 → 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits 452.00M as of 2025-12-31
Lease, Cost 89.40M 2025-01-01 → 2025-12-31
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 59.10M 2025-01-01 → 2025-12-31
Finance Lease, Liability, to be Paid, Year One 33.70M as of 2025-12-31
Finance Lease, Liability, to be Paid, Year Two 727.60M as of 2025-12-31
Finance Lease, Liability, to be Paid, Year Three 0 as of 2025-12-31
Finance Lease, Liability, to be Paid, Year Four 0 as of 2025-12-31
Finance Lease, Liability, to be Paid, Year Five 0 as of 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities 158.80M as of 2025-12-31
Finance Lease, Liability, to be Paid, after Year Five 0 as of 2025-12-31
Finance Lease, Liability, Payment, Due 761.30M as of 2025-12-31
Deferred Tax Assets, Property, Plant and Equipment 192.60M as of 2025-12-31
Finance Lease, Liability, Undiscounted Excess Amount 41.30M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year One 52.10M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Two 52.30M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Three 48.50M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Four 40.30M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Five 31.20M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, after Year Five 97.50M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid 321.90M as of 2025-12-31
Deferred Tax Assets, Other 49.90M as of 2025-12-31
Deferred Tax Assets, Gross 4.08B as of 2025-12-31
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 55.10M as of 2025-12-31
Deferred Tax Assets, Net 4.08B as of 2025-12-31
Deferred Tax Liabilities, Unrealized Gains on Trading Securities 1.90M as of 2025-12-31
Assets, Fair Value Disclosure 17.87B as of 2025-12-31
Defined Contribution Plan, Cost 95.70M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits 1.58B as of 2025-12-31
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 43.10M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 401.90M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Interest on Income Taxes Expense 201.70M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits that Would Impact Effective Tax Rate 520.90M as of 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Domestic -476.30M 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Foreign 5.71B 2025-01-01 → 2025-12-31
Debt Securities, Available-for-sale, Amortized Cost 15.62B as of 2025-12-31
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 1.00B 2025-01-01 → 2025-12-31
Unit segment · 1 concept
Label Value Period
Number of Reportable Segments 1 2025-01-01 → 2025-12-31

Other

1 concepts 1 unit
Unit US$ · 1 concept
Label Value Period
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture 637.40M 2025-01-01 → 2025-12-31

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (REGN CIK 0000872589), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.